- Home
- Blogs
Editing the future: A brief introduction to CRISPR
Browse this blog post
Related news and insights
Publications: 14 March 2024
Infringing gin part II: Court of Appeal victory for M&S against Aldi’s copycat design
News: 09 February 2024
Allen & Overy advises Sartorius group on EUR1.4bn equity raising
News: 09 February 2024
Allen & Overy advises Exponent on investment in Chanelle Pharma
Blog Post: 04 January 2024
The EU Cyber Resilience Act proposal – What You Need to Know
For those with an interest in life sciences, the rise to prominence of CRISPR has been impossible to ignore. It seems a day does not go by without the discovery of a new application for the technology or a new variant of one of the essential components of the system, or a yet another twist in the on-going patent dispute between the would-be inventors of the foundational IP.
As a firm, Allen & Overy is closely following the development of this ground-breaking technology. Our article below aims to set out the basic principles behind the technology, why it has taken the scientific world by storm and outline why the patent dispute matters.
For more information about Allen & Overy’s CRISPR microsite, please click here.
This post was originally co-authored by Daniel Lim.